IBM Curam Social Program Management up to 6.0.4.4 cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.4 | $0-$5k | 0.00 |
Summary
A vulnerability described as problematic has been identified in IBM Curam Social Program Management up to 6.0.4.4. The impacted element is an unknown function. The manipulation results in cross site scripting. This vulnerability is identified as CVE-2014-6091. The attack can be executed remotely. There is not any exploit available. Upgrading the affected component is recommended.
Details
A vulnerability classified as problematic has been found in IBM Curam Social Program Management up to 6.0.4.4 (Business Process Management Software). Affected is an unknown code block. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. CVE summarizes:
Cross-site scripting (XSS) vulnerability in IBM Curam Social Program Management (SPM) 6.0.4 before 6.0.4.5 iFix7 allows remote authenticated users to inject arbitrary web script or HTML via a crafted URL.
The weakness was released 09/23/2014 (Website). The advisory is shared for download at www-01.ibm.com. This vulnerability is traded as CVE-2014-6091 since 09/02/2014. It is possible to launch the attack remotely. The requirement for exploitation is a authentication. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
It is declared as highly functional.
Upgrading to version 6.0.4.5 eliminates this vulnerability.
The vulnerability is also documented in the databases at X-Force (95869) and SecurityFocus (BID 70098†). VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 3.5VulDB Meta Temp Score: 3.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Highly functional
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: Curam Social Program Management 6.0.4.5
Timeline
09/02/2014 🔍09/19/2014 🔍
09/23/2014 🔍
09/23/2014 🔍
03/26/2015 🔍
03/21/2018 🔍
Sources
Vendor: ibm.comAdvisory: www-01.ibm.com
Status: Confirmed
Confirmation: 🔍
CVE: CVE-2014-6091 (🔍)
GCVE (CVE): GCVE-0-2014-6091
GCVE (VulDB): GCVE-100-71496
X-Force: 95869 - IBM Curam Social Program Management cross-site scripting
SecurityFocus: 70098 - IBM Cúram Social Program Management CVE-2014-6091 Cross Site Scripting Vulnerability
Entry
Created: 03/26/2015 16:14Updated: 03/21/2018 09:56
Changes: 03/26/2015 16:14 (55), 03/21/2018 09:56 (2)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.